Clinical Trials Directory

Trials / Unknown

UnknownNCT03390582

Gut Microbiota is Associated With Autoimmune Thyroid Disease

Gut Microbiota is Associated With Autoimmune Thyroid Disease(GD and HT)

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
First Affiliated Hospital of Harbin Medical University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Autoimmune thyroid disease (AITD), which includes Hashimoto's thyroiditis (HT) and Grave's disease (GD), are the most common organ-specific autoimmune diseases and affect more women than men, with a female-to-male ratio from 5 to 10. Many studies have indicated that alterations in the gut microbiota are important environmental factors in the development of inflammatory and autoimmune diseases. Investigators systematically performed a comparative analysis of the gut microbiota in AITD patients and healthy controls.

Detailed description

Autoimmune thyroid disease (AITD), which includes Hashimoto's thyroiditis (HT) and Grave's disease (GD), are the most common organ-specific autoimmune diseases and affect more women than men, with a female-to-male ratio from 5 to 10. These two diseases are clinically diverse because in HT, T cells aid in the destruction of the thyroid epithelial cells (thyrocytes) and thyroid epithelial structure and eventual fibrous replacement of parenchymal tissue leading to hypothyroidism, whereas GD is primarily a humoral disease where auto-antibodies are generated against the thyroid stimulating hormone receptor (TSHR) leading to hyperthyroidism (2,163-165). However, these diseases still share several immunological features,and the disease may progress from one state to another as the autoimmune process evolves. Many studies have indicated that alterations in the gut microbiota are important environmental factors in the development of inflammatory and autoimmune diseases. Investigators systematically performed a comparative analysis of the gut microbiota in AITD patients and healthy controls.

Conditions

Interventions

TypeNameDescription
DRUGMethimazole PillHyperthyroidism patients are treated with Methimazole Pill according to the guidelines

Timeline

Start date
2017-04-20
Primary completion
2018-12-24
Completion
2021-11-01
First posted
2018-01-04
Last updated
2018-01-04

Locations

1 site across 1 country: China

Regulatory

Source: ClinicalTrials.gov record NCT03390582. Inclusion in this directory is not an endorsement.